BTN3A2 and ovarian cancer: Further studies in a larger cohort of 199 high-grade EOC patients confirmed that the protein expression of BTN3A2 in ovarian cancer tissues is positively correlated with the intraepithelial infiltration of CD4+ and CD8+ T cells (39).